Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06783803

Application of Linkage Analysis in the Identification of Novel Hereditary Factors in Familial Aneurysms

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
IRCCS Policlinico S. Donato · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to describe the effectiveness of the application of Linkage Analysis, compared to the standard procedures currently provided by the italian NHS, in the identification of thoracic aortic aneurysms and dissection (TAAD) transmission markers in individuals with familial TAAD.

Detailed description

According to current guidelines, it is important to screen first-degree relatives of patients with familial thoracic aortic aneurysm and dissection (FTAAD) using imaging techniques in order to detect any undiagnosed or asymptomatic cases. The current diagnostic methods for FTAAD involve clinical and instrumental diagnosis. In addition to these methods, genetic analysis through DNA testing, using a blood sample has become an essential tool. The use of massive parallel sequencing (NGS) of multiple genes or the entire exome (Whole Exome Sequencing - WES) is considered the gold standard for genetic diagnosis of FTAAD. However, it should be noted that linkage studies are not currently included in the diagnostic protocols of the Italian National Health System, although they may be helpful in complex familial cases where DNA sequencing has not provided conclusive evidence.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLinkage AnalysisWES-Linkage analysis in families with FTAAD in follow-up in an Italian reference centre for genetic aorthopathies

Timeline

Start date
2024-06-15
Primary completion
2029-05-01
Completion
2029-06-01
First posted
2025-01-20
Last updated
2025-01-20

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06783803. Inclusion in this directory is not an endorsement.